10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
The most prominent of these is the combination of CJC-1295 (a GHRH analog) and Ipamorelin
I asked for an increased dose and they bumped me from .3 to .4
Kaelen Difference Works from cellular level, systemic detox, natural glow, long-term master antioxidant
It maintains exogenous antioxidants i.e